Exploring Structural and Functional Brain Changes in Mild Cognitive

Characteristics of MRI studies included in the meta-analysis of MCI; contingency coefficients obtained from contingency analysis for each affected reg...
0 downloads 0 Views 1MB Size
Subscriber access provided by WEBSTER UNIV

Article

Exploring structural and functional brain changes in mild cognitive impairment: a whole brain ALE meta-analysis for multimodal MRI Lihua Gu, and Zhi-jun Zhang ACS Chem. Neurosci., Just Accepted Manuscript • DOI: 10.1021/acschemneuro.9b00045 • Publication Date (Web): 26 Feb 2019 Downloaded from http://pubs.acs.org on February 27, 2019

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 19 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Chemical Neuroscience

1

Exploring structural and functional brain changes in mild cognitive impairment:

2

a whole brain ALE meta-analysis for multimodal MRI

3 4

Lihua Gua, Zhijun Zhanga, *

5

a

6

Department of Neurology, Affiliated ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China;

7

*Corresponding

8

Zhijun Zhang, PhD, MD

9 10

Department of Neurology, Affiliated ZhongDa Hospital, Medical School, Southeast University, No. 87 Dingjiaqiao Road, Nanjing, Jiangsu, China, 210009.

11

E-mail: [email protected];

12

Tel: 0086-25-83262241;

13

Fax: 0086-25-83285132.

author:

14 15 16 17

Abstract:

18

Background: Unravelling novel biomarkers for mild cognitive impairment (MCI) was

19

highlighted in the prevention and modification of Alzheimer’s disease (AD).

20

Inconsistent results for comparison between MCI patients and healthy controls (HC)

21

were obtained from previous neuroimaging studies.

22

Methods: An activation likelihood estimation (ALE) meta-analysis was made for

23

multimodal neuroimaging in MCI. After initial research and step-by-step exclusions

24

procedures, n = 101 articles (MCI: n = 2681, HC: n = 2941, respectively) were included

25

in the study.

26

Results: It detected MCI related gray matter atrophy in the bilateral medial temporal

27

lobe and white matter abnormity in the left posterior cingulate, parahippocampal gyrus,

28

thalamus, caudate and bilateral precuneus. It revealed MCI-related decreased resting-

29

state activity in the left superior temporal gyrus, right posterior cingulate/precuneus,

30

uncus and hyperactivation in the inferior parietal lobule, superior parietal lobule

31

compared to HC. Task-related functional neuroimaging studies indicated MCI-related

32

hypoactivation in the left inferior parietal lobule, right posterior cingulate, the bilateral

33

precuneus and hyperactivation in the left middle frontal gyrus, superior parietal lobule,

34

insula, superior temporal gyrus and right inferior frontal gyrus. Conclusions: Via this

35

ALE meta-analysis, we obtained these key regions suffering from different kinds of 1

ACS Paragon Plus Environment

ACS Chemical Neuroscience 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

36

deficits in MCI. These regional abnormalities in MRI studies might serve as biomarkers

37

for early diagnosis of MCI.

38 39

Keywords: activation likelihood estimation, meta-analysis, mild cognitive impairment,

40

multimodal magnetic resonance imaging, Alzheimer’s disease; biomarker.

2

ACS Paragon Plus Environment

Page 2 of 19

Page 3 of 19 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Chemical Neuroscience

41

Introduction

42

Alzheimer’s disease (AD) is the most common dementia form in the world 1, 2. AD

43

is a kind of neurodegenerative disease with a progressive age-related decrease in

44

cognitive functions and eventually disability due to sensory, motor impairments and

45

psychiatric conditions 3. Two pathological deficits, neuritic plaques formed by amyloid-

46

β (Aβ) deposition and neurofibrillary tangles derived from hyperphosphorylated tau

47

protein, are critical hallmarks of this neural degenerative disease. The World Health

48

Organization (WHO) reported that by 2050, 1 of 85 persons in global world would be

49

living with AD 4. Therefore, early and accurate detection of AD is essential for

50

lightening the economic load of worldwide healthcare system. Mild cognitive

51

impairment (MCI) is considered as the prodromal period of AD 5. Epidemiological

52

investigations verified that MCI patients develop into dementia at an annual rate of 10-

53

15% 6, whereas normal elderly have a conversion rate of 1-2% per year 7. MCI patients

54

fulfilled the following criteria

55

impairment in daily activities; absence of dementia, symptoms that were insufficient to

56

meet the criteria of National Institute of Neurological and Communicative Disorders

57

and Stroke or the AD and Related Disorders Association (NINCDS-ADRDA) for AD.

58

MCI diagnosis in the early stage is paramountly crucial for slowing down its

59

progression to AD. However, because of the mild symptom of cognitive impairment,

60

MCI is difficult to be identified from normal elderly. Unravelling novel biomarkers for

61

MCI is highlighted in the prevention and modification of AD.

5, 8:

memory complaints and deficits; no or minimal

62

Magnetic resonance imaging (MRI) is a non-invasive tool with high spatial

63

resolutions. Over the last few decades, various imaging modalities were implemented

64

in AD and MCI studies. Different modalities provided different information for disease

65

diagnosis: structural MRI was applied to observe brain volume 9; diffusion tensor

66

imaging (DTI) was used to explore microstructural features of white matter

67

functional MRI (fMRI) focused on neural activation reflected by hemodynamic

68

response 11. Most investigations adopted a separate modality to diagnose AD or MCI.

69

More efforts should be made to concentrate on integration of different imaging

70

modalities to enhance accuracy of AD or MCI diagnosis. On the other hand,

71

inconsistent results for comparison between MCI patients and healthy controls (HC)

72

were obtained from studies with specific modality especially from fMRI studies, which

73

might result from the heterogeneity of included MCI patients and application of

74

different analysis methods. Thus, to get the key brain regional difference between HC

75

and MCI patients, we focused on summarizing the MRI studies with different 3

ACS Paragon Plus Environment

10;

ACS Chemical Neuroscience 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

76

modalities, respectively. In the systematic review and meta-analysis study, anatomic

77

likelihood estimation (ALE) method, which is a powerful technique for voxel-based

78

neuroimaging studies, was implemented to help search for the key regions of brain

79

pathology in MCI.

80

In our investigation, the aim was to perform a comprehensive review of

81

multimodal MRI studies on MCI patients to give insight to the structural and functional

82

brain changes of MCI and explore key regions suffering from deficits in MCI.

83 84

RESULTS AND DISCUSSION

85

Search results

86

The initial research and step-by-step exclusions procedures were presented in

87

Figure 1. In addition, study characteristics and results were summarized in

88

supplementary table 1. In the n = 101 articles (MCI: n = 2681, HC: n = 2941,

89

respectively), n = 27 studies (MCI: n = 801, HC: n = 821, respectively) made whole-

90

brain voxel-based morphometry (VBM) analysis of MCI-related gray matter (GM)

91

abnormalities, n = 6 investigations (MCI: n = 260, HC: n = 417, respectively) reported

92

disturbed white matter (WM) integrity in MCI patients, n = 28 studies (n = 24

93

blood oxygen level-dependent (BOLD) fMRI studies (MCI: n = 671, HC: n = 671,

94

respectively), n = 4 arterial spin labelling (ASL) fMRI studies (MCI: n = 70, HC: n =

95

81, respectively)) focused on resting-state activation abnormalities in MCI patients, n

96

= 53 task-related fMRI investigations (MCI: n = 879, HC: n = 951, respectively)

97

explored brain activation abnormalities during specific cognitive processing in MCI

98

patients.

99

Results of contingency analysis and Spearman correlation The supplementary table 2 showed the contingency coefficients obtained from contingency analysis between MRI types and abnormality in each region. The present study indicated no significant contingency coefficients for all 49 affected regions, which revealed that the presentation of affected region would not be influenced by MRI types. In addition, Spearman correlation indicated a positive correlation (r = 0.471, p = 0.001) between two variables (Number of anatomical studies in which the area was significantly affected and number of fMRI studies in which the area was significantly affected). The result showed that anatomical and fMRI studies might show concordant results for affected regions. Supplementary figure 1 showed boxplots for age, educational levels or Mini-mental State Examination (MMSE) for both HC and aMCI groups in different types of MRI studies, respectively. The cohorts did not differ in age, educational levels or MMSE.

100 101 102 103 104 105 106 107 108 109 110 111 112

4

ACS Paragon Plus Environment

Page 4 of 19

Page 5 of 19 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

113 114 115

ACS Chemical Neuroscience

Meta-analysis results These studies reflected different aspects (brain atrophy, microstructural abnormity, neuronal network dysfunctions) of MCI-related pathological changes.

116

Abnormal gray and white matter in MCI. ALE results indicated that MCI

117

patients showed significant GM reductions in the bilateral hippocampus and amygdala,

118

the left parahippocampal gyrus and the left uncus, compared to HC (see Figure 2. a and

119

Supplementary table 3). Regarding DTI studies, our study revealed that MCI patients

120

showed reduced fractional anisotropy (FA) values in the posterior cingulate gyrus,

121

parahippocampal gyrus, thalamus, caudate in the left hemisphere and the bilateral

122

precuneus (see Figure 2. b and Supplementary table 3). Our result corresponds to a

123

previous meta-analysis study published in 2012

124

volumetric MRI studies

125

suffering from neuronal loss in AD patients in postmortem autopsy 14. In addition, these

126

regions are long recognized to participate in memory, particularly in encoding and

127

retrieval of memory, which are prominently deficient cognitive domains in MCI

128

patients 15. However, AD showed atrophy in both the anterior and posterior parts of the

129

hippocampus supported by another ALE study 16. A recent ALE meta-analysis study

130

for structural MRI of Parkinson's disease (PD) showed small focal gray matter atrophy

131

in the middle occipital gyrus 17, which is quite different from the regions obtained by

132

our study in MCI. Regarding DTI, it revealed lower FA in the posterior cingulate gyrus,

133

parahippocampal gyrus, thalamus, caudate in the left hemisphere and the bilateral

134

precuneus in MCI patients relative to HC, which is consistent with a meta-analysis for

135

ROI-based DTI studies for MCI published in 2011

136

diffusivity perpendicular (DR), mean diffusivity (MD) in the parahippocampal gyrus,

137

posterior cingulate gyrus, precuneus, entorhinal, retrosplenial, supramarginal and FA

138

in the parahippocampal gyrus WM is associated with cognitive decline

139

study detected that MCI presents more changes in FA and DR over time (from baseline

140

to follow-up after 2.5 years) than HC and this WM abnormity is more prominent in

141

MCI patients with more neuronal degeneration evaluated by cerebrospinal fluid (CSF)

142

total tau 20. An ALE study for DTI studies in PD showed FA reductions in the cingulate

143

bundle near the orbital and anterior cingulate gyri 17, which is quite different from the

144

regions obtained by our study in MCI. Our results suggest that FDG-PET reliably

145

identifies consistent functional brain abnormalities in PD, whereas structural MRI and

146

DTI show only focal alterations and rather inconsistent results. Above investigations

147

provided evidence for the idea that WM abnormity could be an index to diagnose MCI

13.

12

and other ROI-based

Medial temporal lobe is confirmed as a critical structure

18.

5

ACS Paragon Plus Environment

A study indicated that lower

19.

Another

ACS Chemical Neuroscience 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

148

Page 6 of 19

and predict the disease progression.

149

Abnormal resting-state activation in MCI. MCI patients showed decreased

150

resting-state activation than HC in the left superior temporal gyrus, the right

151

posterior cingulate gyrus/precuneus, the right uncus (see Figure 2. c and Supplementary

152

table 3). Compared to HC, MCI patients presented an increase in resting-state activation

153

in the inferior parietal lobule and superior parietal lobule in the left hemisphere (see

154

Figure 2. c and Supplementary table 3). Our result was accordant to a previous meta-

155

analysis for resting-state fMRI (rs-fMRI) in aMCI patients

156

discrepant from this meta-analysis study that MCI patients showed decreased brain

157

activation in the left superior temporal gyrus and the right uncus, which might attribute

158

to the heterogeneity of included disease group. The previous meta-analysis only

159

focused on the amnestic form of MCI. The posterior cingulate gyrus/precuneus and the

160

superior temporal gyrus are considered to play crucial roles in default mode network

161

(DMN)

162

memory encoding and retrieval

163

deposition at early stage of AD and appeared central to AD pathology

164

indicated that MCI patients showed resting-state hyperactivation in the left inferior

165

parietal lobule, which corresponds to a recent ALE study 26. Another region, the left

166

superior parietal lobule is never reported by any ALE study for rs-fMRI study in MCI

167

patients. Up to now, we could not verify whether the hyperactivation in the two regions

168

is associated with a compensatory response for function decrease of other regions or

169

results from other pathological changes, such as an early aberrant excitatory response

170

to Aβ. More studies are essential to interpret the result.

22, 23.

21,

whereas it was quite

The medial temporal lobe (Uncus) and DMN are closely involved in 24, 25.

And these areas are vulnerable to amyloid 24.

Our study

171

Abnormal task-related activation in MCI. In the overall analysis on task-related

172

studies on MCI patients, it indicated decreased brain activation in the left inferior

173

parietal lobule, the right posterior cingulate gyrus and the bilateral precuneus in MCI

174

patients than HC (see Figure 2. d and Supplementary table 4). MCI patients showed

175

hyperactivation relative to HC mainly in the middle frontal gyrus, superior parietal

176

lobule, insula, superior temporal gyrus in the left hemisphere as well as the right inferior

177

frontal gyrus (see Figure 2. d and Supplementary table 4). In our study, brain activation

178

comparison between MCI patients and HC was analysed during different cognitive

179

processing tasks, respectively.

180

During memory encoding, it detected MCI-related brain hypoactivation relative to

181

HC in the posterior cingulate gyrus, parahippocampal gyrus in the right hemisphere and

182

the bilateral precuneus (see Figure 3. a and Supplementary table 4). In addition, MCI 6

ACS Paragon Plus Environment

Page 7 of 19 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Chemical Neuroscience

183

patients showed increased brain activation in the left insula and the right middle frontal

184

gyrus, compared to HC (see Figure 3. a and Supplementary table 4). ALE analysis of

185

memory retrieval task indicated that MCI-related hypoactivation mainly located in the

186

bilateral middle frontal gyrus, the left precuneus and the right middle temporal gyrus

187

(see Figure 3. b and Supplementary table 4). Additionally, MCI-related hyperactivation

188

relative to HC was observed in the right superior frontal gyrus during memory retrieval

189

(see Figure 3. b and Supplementary table 4). Regarding working memory (WM)

190

processing, MCI patients showed decreased activation in the lingual gyrus,

191

posterior cingulate gyrus, precuneus and middle frontal gyrus in the right hemisphere

192

(see Figure 3. c and Supplementary table 4). MCI-related hypoactivation relative to HC

193

located in the left insula and left superior temporal gyrus (see Figure 3. c and

194

Supplementary table 4). During executive processing, MCI patients presented

195

hypoactivation in the left superior temporal gyrus, compared to HC (see Supplementary

196

table 4). No significant MCI-related hyperactivation relative to HC was found during

197

executive processing. In addition, it showed no significant MCI-related hypoactivation

198

during visuospatial processing, compared to HC. Moreover, because of the limited

199

number of relevant investigations, this study did not analyse MCI-related

200

hypoactivation compared to HC in visuospatial function related tasks. Identically, we

201

did not explore the brain activation comparison during semantic processing, divided

202

attention tasks, simple-motor tasks, theory of mind related task and lexical decision

203

tasks.

204

Regarding ALE studies for task-related fMRI investigations, discussion was made

205

for specific tasks. During memory encoding, our ALE result corresponds to a recent

206

study that hypoactivation was shown in the right parahippocampal gyrus in MCI

207

patients relative to HC 27. Our investigation also reported hypoactivation in the right

208

posterior cingulate gyrus and bilaterally in the precuneus in MCI patients during this

209

task. These regions play a crucial role in DMN, which is strongly associated with

210

memory encoding and retrieval 24, 25. And the result was in-line with the brain atrophy

211

in these regions 28. During memory retrieval, consistent with our result, another meta-

212

analysis study also indicated the hypoactivation in the bilateral middle frontal gyrus

213

and the left precuneus 26. Together with the right middle temporal gyrus, these regions

214

are important regions associated with episodic memory 29. Hypoactivation in the lingual

215

gyrus, posterior cingulate gyrus, precuneus and middle frontal gyrus in the right

216

hemisphere was detected in MCI patients relative to HC during WM task. These regions

217

are important WM related regions. In addition, multimodal neuroimaging studies, 7

ACS Paragon Plus Environment

ACS Chemical Neuroscience 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 8 of 19

30,

218

including fluorodeoxyglucose positron emission topography (PET)

219

imaging

220

abnormity in these regions at early stage of AD and MCI patients than HC. Some of

221

our results for hyperactivation of regions in MCI relative to HC correspond to another

222

ALE studies for MCI in task-related fMRI studies 26. The supplementary materials of

223

this article reported the consistent results to our study that hyperactivation in MCI

224

relative to HC presented in the right middle frontal gyrus during episodic encoding task

225

and in the left superior temporal gyrus, the left insula during WM and executive

226

function related tasks. The hyperactivation in these regions for MCI during specific task

227

might be compensatory responses to AD pathology 34, 35.

31,

fMRI

32

and β-amyloid imaging

33,

structural

provided converging evidence for

228

Our study reported some limitations. First, heterogeneity between the individual

229

studies could not be investigated via ALE meta-analysis. However, the present study

230

tried to minimize the heterogeneity via the relatively strict inclusion and exclusion

231

criteria. Furthermore, in GingerALE 2.3.6, the ALE algorithm is on the basis of a

232

random-effects model which is more conservative than the fixed-effects model and

233

incorporates both within-study and between-study variance. Second, in meta-analysis

234

for fMRI, different imaging modalities (BOLD or ASL modality) and analysis methods

235

might reflect different facets of neural activation abnormity. Thirdly, ALE technique

236

could not assess the significance level of contributing results.

237 238

CONCLUSIONS

239

The study summarized different aspects of pathological characteristics in MCI

240

patients attained from multimodal MRI studies, a technique with high spatial resolution.

241

Via this ALE meta-analysis, we obtained key regions suffering from different kinds of

242

deficits in MCI. In addition, these regional abnormalities in MRI studies might serve as

243

biomarkers for early diagnosis of MCI.

244 245 246

EXPERIMENTAL SECTION The present study was conducted according to Preferred Reporting Items for

247

Systematic Reviews and Meta-Analyses (PRISMA) statement

248

checklist is included as supplementary table 5.

249

Search strategy

36.

A PRISMA 2009

250

PubMed and Web of Science databases were searched for articles published to

251

August 2018. Search terms used were: (“mild cognitive impairment” OR “MCI”) AND

252

(“neuroimaging” OR “magnetic resonance imaging” OR “MRI”). Searches were 8

ACS Paragon Plus Environment

Page 9 of 19 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Chemical Neuroscience

253

limited to publications in English. Duplicates were removed. A total of 7122 unique

254

articles were screened.

255

Inclusion and exclusion criteria

256

All articles referring to structural MRI, DTI and functional MRI investigations on

257

MCI were included in our study. In addition, studies should include both HC and MCI

258

patients as participants. Moreover, these investigations must provide information about

259

Talairach or Montreal Neurologic Institute (MNI) coordinates for comparisons between

260

HC and MCI.

261

Articles were eliminated while they were associated with other diseases and

262

disorders such as schizophrenia, depression, et al. We dropped secondary processing of

263

literature such as reviews and meta-analysis articles. Case studies without group-level

264

statistics were excluded. In addition, our study excluded priori region of interest (ROI)

265

analyses and seed-based functional connectivity analyses.

266

Data collection

267

Titles and abstracts were read by two different individuals. A total of 101 articles

268

were selected to read full-texts according to the inclusion and exclusion criteria

269

displayed above. Following data were recorded from these full-texts: Author,

270

publication years, imaging modalities, methods of analysis, participant demographics

271

(sample size, age, gender, year of education and MMSE, task for task-related fMRI

272

studies, contrasts of included studies, three-dimensional (3D) coordinates and all

273

affected regions.

274

Contingency analysis and Spearman correlation

275

Contingency analysis and Spearman correlation were applied to evaluate whether

276

anatomical (structural MRI and DTI) and fMRI studies (rs-fMRI and task-related fMRI)

277

give concordant results for all affected regions. On the basis of the previous study 37,

278

for each region, every study could be cross classified by MRI types (anatomical or fMRI)

279

and according to whether the brain region is affected, producing a 2 × 2 contingency

280

table of counts. Via contingency analysis, contingency coefficients were obtained to

281

imply the presence of a dependency between MRI types and abnormality in each region

282

(i.e., anatomical studies would present abnormality in the left hippocampus more or

283

less likely). To stabilize results and ensure all cells had sufficient observations for the

284

parametric contingency analysis test, we excluded all regions that were affected in

285

fewer than 3% of studies. In addition, we applied Spearman correlation between two

286

variables (Number of anatomical studies in which the area was significantly affected

287

and number of fMRI studies in which the area was significantly affected) in n = 49 9

ACS Paragon Plus Environment

ACS Chemical Neuroscience 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 10 of 19

288

affected regions to further verify our contingency analysis results. Statistical threshold

289

was set at a p < 0.05. The boxplots were utilized to evaluate the heterogeneity of age,

290

educational levels or MMSE between studies.

291

Meta-analysis procedures

292

An ALE meta-analysis was performed with Java-based version of GingerALE

293

2.3.6 (http://www.brainmap.org/ale). ALE aimed to assess the convergence of

294

difference between groups in terms of foci across studies. The
foci data were read as a

295

text file and imported into the software. Then, all these Talairach coordinates were

296

converted to corresponding MNI coordinates with icbm2tal

297

significance was attained with a permutation test (5000 permutations) on randomly

298

distributed foci. Full-width-half-maximum (FWHM) was calculated according to

299

subjects numbers in each study 40. ALE maps were set a threshold at p < 0.05 using the

300

false discovery rate (FDR) with an extent threshold > 200 mm3. Eventually, the maps

301

were overlaid onto the MNI 152 template and viewed with Mango software

302

(http://rii.uthscsa.edu/mango). ALE studies were performed for structural MRI, DTI,

303

rs-fMRI and all task-related fMRI investigations in MCI. In addition, our study focused

304

on specific cognitive task-related fMRI studies in MCI, respectively.

38, 39.

Statistical

305 306

AUTHOR INFORMATION

307

Corresponding Authors

308

311

* Zhijun Zhang, PhD, MD: Department of Neurology, Affiliated ZhongDa Hospital, Medical School, Southeast University, No. 87 Dingjiaqiao Road, Nanjing, Jiangsu, China, 210009. E-mail: [email protected]; Tel: 0086-2583262241; Fax: 0086-25-83285132.

312

Author Contributions

309 310

313

Zhijun Zhang contributed to the design and plan of the present study. Zhijun Zhang

314

supervised the project. Lihua Gu was in charge of article inclusion and had the major

315

responsibility for analysis and manuscript writing.

316

Funding

317

This study was supported by the National Natural Science Foundation of China

318

(No. 81420108012; 81671046), the Key Program for Clinical Medicine and Science

319

and Technology: Jiangsu Province Clinical Medical Research Center (No. BL2013025;

320

BL2014077).

321

Notes

322

The authors declare no competing financial interest. 10

ACS Paragon Plus Environment

Page 11 of 19 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

323

ACS Chemical Neuroscience

ACKNOWLEDGEMENTS

324

We are grateful for the assistance for article inclusion of Lijuan Gao of the

325

Department of Neurology, Affiliated ZhongDa Hospital, Medical School, Southeast

326

University.

327

SUPPORTING INFORMATION: Supplementary material (Supplementary tables 1,

328

2, 3, 4 and 5; supplementary figure 1; supplementary references) is available free of

329

charge via the internet.

330

ABBREVIATIONS USED AD, Alzheimer’s disease; ALE, activation likelihood estimation; Aβ, amyloid-β; ASL, arterial spin labelling; BOLD, blood oxygen level-dependent; CSF, cerebrospinal fluid; DMN, default mode network; DR, diffusivity perpendicular; DTI, diffusion tensor imaging; FDR, false discovery rate; fMRI, functional magnetic resonance imaging; FWHM, full-width-half-maximum; GM, gray matter; HC, healthy controls; MCI, mild cognitive impairment; MD, mean diffusivity; MMSE, Mini-mental State Examination; MNI, Montreal Neurologic Institute; MRI, magnetic resonance imaging; PET, positron emission topography; ROI, region of interest; 3D, three-dimensional; VBM, voxelbased morphometry; WM, white matter.

331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364

References 1. Blennow, K., de Leon, M. J., and Zetterberg, H. (2006) Alzheimer's disease, Lancet (London, England) 368, 387-403. 2. Cummings, J. L. (2004) Alzheimer's disease, The New England journal of medicine 351, 56-67. 3. Reichman, W. E., and Rose, N. S. (2012) History and experience: the direction of Alzheimer's disease, Menopause (New York, N.Y.) 19, 724-734. 4. Brookmeyer, R., Johnson, E., Ziegler-Graham, K., and Arrighi, H. M. (2007) Forecasting the global burden of Alzheimer’s disease, Alzheimers & Dementia 3, 186191. 5. Petersen, R. C., Stevens, J. C., Ganguli, M., Tangalos, E. G., Cummings, J. L., and DeKosky, S. T. (2001) Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology, Neurology 56, 1133-1142. 6. M, G., RC, P., SH, F., RG, T., PS, A., DA, B., NL, F., Jr, J. C., DR, G., R, D., J, K., M, S., R, M., S, G., HT, K., S, J., AN, S., K, S., R, M., CH, v. D., J, M., EY, Z., D, C.-W., LJ, T., and Study, A. s. D. C. (2004) Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials, Jama Neurology 61, 59-66. 7. Bischkopf, J., Busse, A., and Angermeyer, M. C. (2002) Mild cognitive impairment—A review of prevalence, incidence and outcome according to current approaches, Acta Psychiatrica Scandinavica 106, 403-414. 8. Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., and Kokmen, E. (1999) Mild cognitive impairment: clinical characterization and outcome, 11

ACS Paragon Plus Environment

ACS Chemical Neuroscience 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408

Archives of neurology 56, 303-308. 9. Tabatabaei-Jafari, H., Shaw, M. E., and Cherbuin, N. (2015) Cerebral atrophy in mild cognitive impairment: A systematic review with meta-analysis, Alzheimer's & dementia (Amsterdam, Netherlands) 1, 487-504. 10. Zhang, B., Xu, Y., Zhu, B., and Kantarci, K. (2014) The role of diffusion tensor imaging in detecting microstructural changes in prodromal Alzheimer's disease, CNS neuroscience & therapeutics 20, 3-9. 11. Farras-Permanyer, L., Guardia-Olmos, J., and Pero-Cebollero, M. (2015) Mild cognitive impairment and fMRI studies of brain functional connectivity: the state of the art, Frontiers in psychology 6, 1095. 12. Jing, Y., Pan, P. L., Wei, S., Rui, H., Li, J. P., Ke, C., Gong, Q. Y., Zhong, J. G., Shi, H. C., and Shang, H. F. (2012) Voxelwise meta-analysis of gray matter anomalies in Alzheimer's disease and mild cognitive impairment using anatomic likelihood estimation, Journal of the Neurological Sciences 316, 21-29. 13. Research, C. A. (2009) Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort, Current Alzheimer Research 6, 347-361(315). 14. Braak, H., and Braak, E. (1995) Staging of alzheimer's disease-related neurofibrillary changes, Neurobiology of Aging 16, 271-278. 15. Blennow, K., Leon, M. J. D., and Zetterberg, H. (2006) Alzheimer's disease, Lancet 368, 387-403. 16. Chapleau, M., Aldebert, J., Montembeault, M., and Brambati, S. M. (2016) Atrophy in Alzheimer's Disease and Semantic Dementia: An ALE Meta-Analysis of VoxelBased Morphometry Studies, Journal of Alzheimer's disease : JAD 54, 941-955. 17. Albrecht, F., Ballarini, T., Neumann, J., and Schroeter, M. L. (2018) FDG-PET hypometabolism is more sensitive than MRI atrophy in Parkinson's disease: A wholebrain multimodal imaging meta-analysis, NeuroImage. Clinical. 18. Sexton, C. E., Kalu, U. G., Filippini, N., Mackay, C. E., and Ebmeier, K. P. (2011) A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease, Neurobiology of Aging 32, 2322.e2325–2322.e2318. 19. Selnes, P., Aarsland, D., Bjornerud, A., Gjerstad, L., Wallin, A., Hessen, E., Reinvang, I., Grambaite, R., Auning, E., Kjaervik, V. K., Due-Tonnessen, P., Stenset, V., and Fladby, T. (2013) Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment, Journal of Alzheimer's disease : JAD 33, 723-736. 20. Amlien, I. K., Fjell, A. M., Walhovd, K. B., Selnes, P., Stenset, V., Grambaite, R., Bjornerud, A., Due-Tonnessen, P., Skinningsrud, A., Gjerstad, L., Reinvang, I., and Fladby, T. (2013) Mild cognitive impairment: cerebrospinal fluid tau biomarker pathologic levels and longitudinal changes in white matter integrity, Radiology 266, 295-303. 21. Lau, W. K. W., M-K, L., Lee, T. M. C., and Law, A. C. K. (2016) Resting-state abnormalities in amnestic mild cognitive impairment: a meta-analysis, Translational Psychiatry 6, e790. 22. Petrella, J. R., Sheldon, F. C., Prince, S. E., Calhoun, V. D., and Doraiswamy, P. 12

ACS Paragon Plus Environment

Page 12 of 19

Page 13 of 19 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452

ACS Chemical Neuroscience

M. (2011) Default mode network connectivity in stable vs progressive mild cognitive impairment, Neurology 76, 511-517. 23. Liu, Z., Zhang, Y., Bai, L., Yan, H., Dai, R., Zhong, C., Wang, H., Wei, W., Xue, T., Feng, Y., You, Y., and Tian, J. (2012) Investigation of the effective connectivity of resting state networks in Alzheimer's disease: a functional MRI study combining independent components analysis and multivariate Granger causality analysis, NMR in biomedicine 25, 1311-1320. 24. Sperling, R. A., Dickerson, B. C., Pihlajamaki, M., Vannini, P., LaViolette, P. S., Vitolo, O. V., Hedden, T., Becker, J. A., Rentz, D. M., Selkoe, D. J., and Johnson, K. A. (2010) Functional alterations in memory networks in early Alzheimer's disease, Neuromolecular medicine 12, 27-43. 25. Pihlajamäki, M., Jauhiainen, A. M., and Soininen, H. (2009) Structural and functional MRI in mild cognitive impairment, Current Alzheimer research 6, 179-185. 26. Li, H. J., Hou, X. H., Liu, H. H., Yue, C. L., He, Y., and Zuo, X. N. (2014) Toward systems neuroscience in mild cognitive impairment and Alzheimer's disease: A metaanalysis of 75 fMRI studies, Human brain mapping 36, 1217–1232. 27. Browndyke, J. N., Giovanello, K., Petrella, J., Hayden, K., Chiba-Falek, O., Tucker, K. A., Burke, J. R., and Welsh-Bohmer, K. A. (2013) Phenotypic regional functional imaging patterns during memory encoding in mild cognitive impairment and Alzheimer's disease, Alzheimer's & dementia : the journal of the Alzheimer's Association 9, 284-294. 28. Ewers, M., Sperling, R. A., Klunk, W. E., Weiner, M. W., and Hampel, H. (2011) Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia, Trends in neurosciences 34, 430-442. 29. Rajah, M. N., Languay, R., and Grady, C. L. (2011) Age-related changes in right middle frontal gyrus volume correlate with altered episodic retrieval activity, Journal of Neuroscience the Official Journal of the Society for Neuroscience 31, 17941-17954. 30. MD, S. M. P., Giordani., B., Berent., S., MD, K. A. F. P., Foster, N. L., and Kuhl, D. E. (1997) Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease, Annals of Neurology 42, 85–94. 31. Whitwell, J. L., Shiung, M. M., Przybelski, S. A., Weigand, S. D., Knopman, D. S., Boeve, B. F., Petersen, R. C., and Jr, J. C. (2008) MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment, Neurology 70, 512520. 32. Kochan, N. A., Breakspear, M., Slavin, M. J., Valenzuela, M., McCraw, S., Brodaty, H., and Sachdev, P. S. (2010) Functional alterations in brain activation and deactivation in mild cognitive impairment in response to a graded working memory challenge, Dementia and geriatric cognitive disorders 30, 553-568. 33. Kemppainen, N. M., Aalto, S., Wilson, I. A., Någren, K., Helin, S., Brück, A., Oikonen, V., Kailajärvi, M., Scheinin, M., and Viitanen, M. (2007) PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment, Neurology 68, 1603-1606. 34. Kircher, T. T., Weis, S., Freymann, K., Erb, M., Jessen, F., Grodd, W., Heun, R., and Leube, D. T. (2007) Hippocampal activation in patients with mild cognitive impairment is necessary for successful memory encoding, Journal of Neurology 13

ACS Paragon Plus Environment

ACS Chemical Neuroscience 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476

Neurosurgery & Psychiatry 78, 812-818. 35. Bokde, A. L., Karmann, M., Born, C., Teipel, S. J., Omerovic, M., Ewers, M., Frodl, T., Meisenzahl, E., Reiser, M., and Möller, H. J. (2014) Altered brain activation during a verbal working memory task in subjects with amnestic mild cognitive impairment, Journal of Alzheimers Disease Jad 10, 103-118. 36. Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., and Group, T. P. (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement, Revista Española De Nutrición Humana Y Dietética. 37. Yarkoni, T., Poldrack, R. A., Nichols, T. E., Van Essen, D. C., and Wager, T. D. (2011) Large-scale automated synthesis of human functional neuroimaging data, Nature methods 8, 665-670. 38. Laird, A. R., Robinson, J. L., McMillan, K. M., Tordesillas-Gutierrez, D., Moran, S. T., Gonzales, S. M., Ray, K. L., Franklin, C., Glahn, D. C., Fox, P. T., and Lancaster, J. L. (2010) Comparison of the disparity between Talairach and MNI coordinates in functional neuroimaging data: validation of the Lancaster transform, NeuroImage 51, 677-683. 39. Lancaster, J. L., Tordesillas-Gutierrez, D., Martinez, M., Salinas, F., Evans, A., Zilles, K., Mazziotta, J. C., and Fox, P. T. (2007) Bias between MNI and Talairach coordinates analyzed using the ICBM-152 brain template, Human brain mapping 28, 1194-1205. 40. Turkeltaub, P. E., Eickhoff, S. B., Laird, A. R., Fox, M., Wiener, M., and Fox, P. (2012) Minimizing within-experiment and within-group effects in Activation Likelihood Estimation meta-analyses, Human brain mapping 33, 1-13.

14

ACS Paragon Plus Environment

Page 14 of 19

Page 15 of 19 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Chemical Neuroscience

477 478

Figure Legends

479

Figure 1. Flow of information through the different phases of a systematic review.

480 481

Figure 2. (a) Gray matter reduction in patients with MCI patients compared with HC

482

(in blue). (b) Lower FA in MCI patients relative to HC (in blue). (c) Resting-state

483

hypoactivation (in blue) and hyperactivation (in red) in MCI patients relative to HC. (d)

484

Hypoactivation (in blue) and hyperactivation (in red) in MCI patients relative to HC in

485

task-related studies. Abbreviations: AMYG, amygdala; CAU, caudate; FA, fractional

486

anisotropy; HC, healthy controls; HIP, hippocampus; IFG, inferior frontal gyrus; INS,

487

insula; IPL, inferior parietal lobule; MCI, mild cognitive impairment; MFG, middle

488

frontal gyrus; PHG, parahippocampal; PCG, posterior cingulate; PCUN, precuneus;

489

SPL, superior parietal lobule; STG, superior temporal gyrus; THA, thalamus.

490 491

Figure 3. (a) Hypoactivation (in blue) and hyperactivation (in red) in MCI relative to

492

HC during memory encoding. (b) Hypoactivation (in blue) and hyperactivation (in red)

493

in MCI patients relative to healthy controls during memory retrieval. (c) Hypoactivation

494

(in blue) and hyperactivation (in red) in MCI patients relative to healthy controls during

495

WM task. Abbreviation: INS, insula; LING, lingual gyrus; MCI, mild cognitive

496

impairment; MFG, middle frontal gyrus; MTG, middle temporal gyrus; PHG,

497

parahippocampal; PCG, posterior cingulate; PCUN, precuneus; SFG, superior frontal

498

gyrus; STG, superior temporal gyrus; WM, working memory.

499

15

ACS Paragon Plus Environment

ACS Chemical Neuroscience 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Figure 1. Flow of information through the different phases of a systematic review.

ACS Paragon Plus Environment

Page 16 of 19

Page 17 of 19 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Chemical Neuroscience

Figure 2. (a) Gray matter reduction in patients with MCI patients compared with HC (in blue). (b) Lower FA in MCI patients relative to HC (in blue). (c) Resting-state hypoactivation (in blue) and hyperactivation (in red) in MCI patients relative to HC. (d) Hypoactivation (in blue) and hyperactivation (in red) in MCI patients relative to HC in task-related studies. Abbreviations: AMYG, amygdala; CAU, caudate; FA, fractional anisotropy; HC, healthy controls; HIP, hippocampus; IFG, inferior frontal gyrus; INS, insula; IPL, inferior parietal lobule; MCI, mild cognitive impairment; MFG, middle frontal gyrus; PHG, parahippocampal; PCG, posterior cingulate; PCUN, precuneus; SPL, superior parietal lobule; STG, superior temporal gyrus; THA, thalamus.

ACS Paragon Plus Environment

ACS Chemical Neuroscience 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Figure 3. (a) Hypoactivation (in blue) and hyperactivation (in red) in Mild cognitive impairment relative to healthy controls during memory encoding. (b) Hypoactivation (in blue) and hyperactivation (in red) in MCI patients relative to healthy controls during memory retrieval. (c) Hypoactivation (in blue) and hyperactivation (in red) in MCI patients relative to healthy controls during WM task. Abbreviation: INS, insula; LING, lingual gyrus; MFG, middle frontal gyrus; MTG, middle temporal gyrus; PHG, parahippocampal; PCG, posterior cingulate; PCUN, precuneus; SFG, superior frontal gyrus; STG, superior temporal gyrus; WM, working memory.

ACS Paragon Plus Environment

Page 18 of 19

Page 19 of 19 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Chemical Neuroscience

ACS Paragon Plus Environment